# A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

> **NCT06915246** · PHASE2 · RECRUITING · sponsor: **VIVUS LLC** · enrollment: 49 (estimated)

## Conditions studied

- Lymphoma
- Non-Hodgkin Lymphoma
- Hodgkin Lymphoma

## Interventions

- **DRUG:** VI-0609
- **DRUG:** BiCNU

## Key facts

- **NCT ID:** NCT06915246
- **Lead sponsor:** VIVUS LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-12
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-04-30
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06915246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06915246, "A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06915246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*